Adaptive Biotechnologies Corporation (ADPT) Earnings History
Annual and quarterly earnings data from 2017 to 2025
Loading earnings history...
ADPT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ADPT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 74.2% | -20.6% | -21.5% |
| 2024 | 59.7% | -90.8% | -89.1% |
| 2023 | 55.6% | -133.3% | -132.3% |
| 2022 | 68.7% | -108.0% | -108.0% |
| 2021 | 68.1% | -135.4% | -134.3% |
Download Data
Export ADPT earnings history in CSV or JSON format
Free sign-in required to download data
Adaptive Biotechnologies Corporation (ADPT) Earnings Overview
As of May 8, 2026, Adaptive Biotechnologies Corporation (ADPT) reported trailing twelve-month net income of -$50M, reflecting +63.9% year-over-year growth. The company earned $-0.32 per diluted share over the past four quarters, with a net profit margin of -21.5%.
Looking at the long-term picture, ADPT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$43M in fiscal 2017.
Adaptive Biotechnologies Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NTRA (-$208M net income, -9.0% margin), EXAS (-$208M net income, -6.4% margin), PACB (-$546M net income, -341.5% margin), ADPT has room to improve margins relative to the peer group. Compare ADPT vs NTRA →
ADPT Earnings vs Peers
Earnings metrics vs comparable public companies
ADPT Historical Earnings Data (2017–2025)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$59M | +62.7% | -$57M | $-0.39 | -21.5% | -20.6% |
| 2024 | -$159M | +29.2% | -$163M | $-1.08 | -89.1% | -90.8% |
| 2023 | -$225M | -12.5% | -$227M | $-1.56 | -132.3% | -133.3% |
| 2022 | -$200M | +3.4% | -$200M | $-1.00 | -108.0% | -108.0% |
| 2021 | -$207M | -41.8% | -$209M | $-1.46 | -134.3% | -135.4% |
| 2020 | -$146M | -113.1% | -$153M | $-1.06 | -148.6% | -155.3% |
| 2019 | -$69M | -47.7% | -$78M | $-0.47 | -80.6% | -92.1% |
| 2018 | -$46M | -8.4% | -$50M | $-0.44 | -83.4% | -89.4% |
| 2017 | -$43M | - | -$44M | $-0.41 | -111.4% | -115.7% |
See ADPT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADPT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADPT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonADPT — Frequently Asked Questions
Quick answers to the most common questions about buying ADPT stock.
Is ADPT growing earnings?
ADPT EPS is $-0.32, with earnings growth accelerating to +63.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-50M.
What are ADPT's profit margins?
Adaptive Biotechnologies Corporation net margin is -21.5%, with operating margin at -20.6%. Below-average margins reflect competitive or cost pressures.
How consistent are ADPT's earnings?
ADPT earnings data spans 2017-2025. The accelerating earnings trend is +63.9% YoY. Historical data enables comparison across business cycles.